These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B. Liu J; Budylowski P; Samson R; Griffin BD; Babuadze G; Rathod B; Colwill K; Abioye JA; Schwartz JA; Law R; Yip L; Ahn SK; Chau S; Naghibosadat M; Arita Y; Hu Q; Yue FY; Banerjee A; Hardy WR; Mossman K; Mubareka S; Kozak RA; Pollanen MS; Martin Orozco N; Gingras AC; Marcusson EG; Ostrowski MA Sci Adv; 2022 Jan; 8(3):eabj9815. PubMed ID: 35044832 [TBL] [Abstract][Full Text] [Related]
24. What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients? Silvestris N EBioMedicine; 2021 Dec; 74():103733. PubMed ID: 34864362 [No Abstract] [Full Text] [Related]
25. Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines. Al Jalali V; Scherzer S; Zeitlinger M Clin Microbiol Infect; 2021 Oct; 27(10):1529-1530. PubMed ID: 34192576 [No Abstract] [Full Text] [Related]
26. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months. Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients. Bloomfield M; Parackova Z; Hanzlikova J; Lastovicka J; Sediva A J Clin Immunol; 2022 Feb; 42(2):266-269. PubMed ID: 34718945 [No Abstract] [Full Text] [Related]
28. Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis. Martin P; Clarke C EBioMedicine; 2021 Sep; 71():103567. PubMed ID: 34454401 [No Abstract] [Full Text] [Related]
29. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. Kamar N; Abravanel F; Marion O; Couat C; Izopet J; Del Bello A N Engl J Med; 2021 Aug; 385(7):661-662. PubMed ID: 34161700 [No Abstract] [Full Text] [Related]
30. Reflections on SARS-CoV-2 new strain contagiousness and its prevention with mRNA vaccines. García-Vigil JL; García-Alvarez JL Gac Med Mex; 2021; 157(3):318. PubMed ID: 34667321 [No Abstract] [Full Text] [Related]
31. Plasma Neutralization of the SARS-CoV-2 Omicron Variant. Schmidt F; Muecksch F; Weisblum Y; Da Silva J; Bednarski E; Cho A; Wang Z; Gaebler C; Caskey M; Nussenzweig MC; Hatziioannou T; Bieniasz PD N Engl J Med; 2022 Feb; 386(6):599-601. PubMed ID: 35030645 [No Abstract] [Full Text] [Related]
32. Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic. Arellano-Llamas AA; Vela-Ojeda J; Hernandez-Caballero A Curr Oncol Rep; 2022 Feb; 24(2):209-213. PubMed ID: 35061199 [TBL] [Abstract][Full Text] [Related]
34. Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants. Qu P; Faraone JN; Evans JP; Zheng YM; Yu L; Ma Q; Carlin C; Lozanski G; Saif LJ; Oltz EM; Gumina RJ; Liu SL N Engl J Med; 2022 Oct; 387(14):1329-1331. PubMed ID: 36069925 [No Abstract] [Full Text] [Related]
35. Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV. Lv Z; Li Q; Feng Z; Zheng X; NaYin ; Yang H; Gu Q; Ying S; Qi Y; Li X; Wu R; Wu Z; Yu X; Zou N; Qin D; Wan C Int Immunopharmacol; 2022 Jan; 102():108383. PubMed ID: 34824035 [TBL] [Abstract][Full Text] [Related]
36. Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia. Herishanu Y; Avivi I; Levi S; Shefer G; Bronstein Y; Moshiashvili MM; Ziv T; Scarfò L; Perry C; Ghia P Blood Adv; 2022 Jan; 6(1):148-151. PubMed ID: 34614513 [No Abstract] [Full Text] [Related]
37. From mRNA sensing to vaccines. Fauci AS; Merad M; Swaminathan S; Hur S; Topol E; Fitzgerald K; Reis e Sousa C; Corbett KS; Bauer S Immunity; 2021 Dec; 54(12):2676-2680. PubMed ID: 34739870 [TBL] [Abstract][Full Text] [Related]
38. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study. Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185 [TBL] [Abstract][Full Text] [Related]
39. The long road. Cohen J Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838 [No Abstract] [Full Text] [Related]
40. Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients. Boyarsky BJ; Chiang TP; Ou MT; Werbel WA; Massie AB; Segev DL; Garonzik-Wang JM Transplantation; 2021 Aug; 105(8):e82-e83. PubMed ID: 34098566 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]